10-K
Annual Report
ACRO BIOMEDICAL CO., LTD.
CIK: 1622996
File #: 000-55643
Balance Sheet
34 line items · 2 periods
XBRL
| Item | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
Balance Sheets | ||
ASSETS | ||
Current Assets | ||
Cash | 376 | 5,852 |
Accounts Receivable | 0 | 638,500 |
Purchase deposit for inventory | 0 | 12,000 |
Other Non-Operating Current Assets | 1,250 | 1,185 |
Total Current Assets | 1,626 | 657,537 |
Operating Lease Right-of-Use Asset | 52,233 | 25,719 |
Other Non-Operating Current Assets | 4,600 | 4,230 |
TOTAL ASSETS | 58,459 | 687,486 |
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||
Current Liabilities | ||
Accounts Payable | 154,444 | 76,571 |
Other Current Liabilities | 20,000 | 20,000 |
Other Non-Operating Current Liabilities | 88,796 | 78,826 |
CEO | 1,100 | 1,100 |
Operating Lease Liability, Current | 25,335 | 25,719 |
Total Current Liabilities | 288,575 | 201,116 |
Operating Lease Liability, Non-Current | 26,898 | 0 |
TOTAL LIABILITIES | 315,473 | 201,116 |
Stockholders' Equity (Deficit) | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 60,042 | 60,042 |
Total Stockholders' Equity | 32,298,442 | 32,295,236 |
Deferred stock compensation | 0 | 8,060,983 |
Total Stockholders' Equity | (32,615,498) | (23,807,925) |
Total Stockholders' (Deficit) Equity | (257,014) | 486,370 |
Accumulated Deficit | (32,615,498) | (23,807,925) |
Deferred stock compensation | 0 | (8,060,983) |
Additional Paid-In Capital | 32,298,442 | 32,295,236 |
Preferred Stock | 0 | 0 |
Common Stock | 60,042 | 60,042 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | 58,459 | 687,486 |